FDA announces Pharmakon Pharmaceuticals voluntary recall of morphine sulfate 0.5 mg/mL preservative free in 0.9% sodium chloride
[2/16/2016] The U.S. Food and Drug Administration is alerting Health care professionals of a voluntary recall of morphine sulfate 0.5 mg/mL preservative free in 0.9% sodium chloride , 1 mL syringe, CII, for intravenous use made and distributed by Pharmakon Pharmaceuticals, in Noblesville, Indiana, because the product is super-potent. Pharmakon initiated the voluntary recall on February 11, 2016, after receiving laboratory results showing the product was super-potent. Injecting a patient with super-potent morphine could result in serious consequences including respiratory depression, coma, and death . Health care professionals should immediately check their medical supplies, quarantine the recalled product from Pharmakon , and not administer them to patients. The recalled product was made on Februar...